Theme · page 3
Pricing and price sensitivity
Price gaps, copays, premiums and recipe swaps at the same price: how much money changes a decision, and when it does not.
What has Brox published on pricing and price sensitivity?Newest first
-
Half of US streaming subscribers would cancel over an ad-free price increase, but 37.5% would take the ad tier if it were simply offered
50.5% 101 of 200 US streaming subscribers would cancel a service that made its ad-free plan meaningfully more expensive; 37 of 200 would move to the plan with ads, 28 of 200 would shop for an alternative and 23 of 200 would pay the higher price. (base 200)
Read -
Content ends a US streaming subscription and price ends the relationship: 82% would cancel when their one show ends, a $5 rise to $17.99 loses the majority, and at $21.99 42.5% never come back
82% 82% would cancel a $12.99 ad-free service the month the one show they watch it for ends, and come back if something new appeals, and another 6.5% would cancel for good; by contrast a $2 price increase to $14.99 moves 21.5% to cancel, a $5 rise to $17.99 moves 45%, and a $9 rise to $21.99 moves 62.5%. (base 200)
Read -
A 15% cheaper quote moves a third of US insurance customers outright, and puts 59% in play
33.5% 33.5% would switch outright to a quote 15% cheaper for the same coverage, and another 25.5% would ask their insurer to match it and leave only if refused; at 5% cheaper, 9.5% would switch and 80.5% would stay; at 30% cheaper, 45% would switch outright. (base 200)
Read -
Reese's recipe recovery: told of a quiet swap to cheaper chocolate, buy intent fell to 1.3 of 5, and the real recipe back at 15% more won it back to 3.8
1.3 buy-forward intent (of 5) after the quiet recipe swap (base 456)
Read -
Veridian Oncology, an Invented Biotech: M&A Stress Test
18% peak-share assumption after the patient evidence, down from management's 30% (base 958)
Read -
肥満・糖尿病治療薬GLP-1に対する意識調査の詳細分析 | GLP-1 Perception Deep Dive (JP)
900 clones asked how likely they would be to try a GLP-1 at four monthly price points; even free barely moved the needle (base 900)
Read -
Prediktif Fiyat Hassasiyeti Analizi: İlaç | Predictive Price Sensitivity Analysis: Pharma (TR)
7pp point drop in willingness for a severe disease despite a 25x copay increase ($10 to $250) (base 900)
Read -
GLP-1 Derin Algı Analizi | GLP-1 Perception Deep Dive (TR)
900 clones asked how likely they would be to try a GLP-1 at four monthly price points; even free barely moved the needle (base 900)
Read -
製薬分野における価格感度の予測分析 | Predictive Price Sensitivity Analysis: Pharma (JP)
7pp point drop in willingness for a severe disease despite a 25x copay increase ($10 to $250) (base 900)
Read -
GLP-1 Perception Deep Dive
900 clones asked how likely they would be to try a GLP-1 at four monthly price points; even free barely moved the needle (base 900)
Read -
Predictive Price Sensitivity Analysis: Pharma
7pp point drop in willingness for a severe disease despite a 25x copay increase ($10 to $250) (base 900)
Read -
Fees and Interest Dominate: 11 of the Top 15 Credit Card Fixes Lower-Income Customers Want
226 customer-sourced credit card ideas tested (base 2,000)
Read
Other themes
How should you read these findings?
Where the numbers come from. Every figure on this site is a predicted response from Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The base under each figure is the number of clones behind it.
Where the real data comes from. The long-form video interviews with the real people the clones are built from. A quote is always shown with the interview line it was predicted from.
What you can take away. Insights publish their tabulation as CSV and JSON: question, option, count, percentage and base. Never per-person rows.
Ask this of your own customers: humans@brox.ai